MicroRNA-150: A Novel Marker of Left Ventricular Remodeling After Acute Myocardial Infarction

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation: Cardiovascular Genetics

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCGENETICS.113.000077PMID 23547171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of circulating microRNAs to diagnose acute myocardial infarction.

  2012influential reference
• Introduction to the series on microRNAs in the cardiovascular system.

  2012cited by this paper
• Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

  2012influential reference
• Differential Expression of MicroRNAs in Different Disease States

  2012cited by this paper
• Systems-Based Approaches to Cardiovascular Biomarker Discovery

  2012cited by this paper
• Non-cardiomyocyte microRNAs in heart failure.

  2012cited by this paper
• Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis.

  2012cited by this paper
• Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure

  2011cited by this paper
• MicroRNAs, Innate Immunity and Ventricular Rupture in Human Myocardial Infarction

  2011influential reference
• Relationship Between The Temporal Profile of Plasma microRNA and Left Ventricular Remodeling In Patients Following Myocardial Infarction Running title : Zile

  2011cited by this paper
• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

  2011cited by this paper
• Relationship Between the Temporal Profile of Plasma microRNA and Left Ventricular Remodeling in Patients After Myocardial Infarction

  2011cited by this paper
• Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome.

  2011cited by this paper
• microRNAs in hypertrophy and heart failure

  2011cited by this paper
• microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4

  2011cited by this paper
• MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.

  2010cited by this paper
• Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary int

  2010cited by this paper
• Secreted monocytic miR-150 enhances targeted endothelial cell migration.

  2010cited by this paper
• MiR423-5p As a Circulating Biomarker for Heart Failure

  2010cited by this paper
• Processing of Agilent microRNA array data

  2010cited by this paper
• Gene-expression profiling for rejection surveillance after cardiac transplantation.

  2010cited by this paper
• PI3K(p110&agr;) Protects Against Myocardial Infarction-Induced Heart Failure: Identification of PI3K-Regulated miRNA and mRNA

  2010cited by this paper
• C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction.

  2009cited by this paper
• MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis

  2009cited by this paper
• Biomarkers in heart failure.

  2009cited by this paper
• The IntAct molecular interaction database in 2010

  2009cited by this paper
• The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure

  2008cited by this paper
• Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.

  2008cited by this paper
• The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling.

  2008cited by this paper
• Serum MicroRNAs Are Promising Novel Biomarkers

  2008cited by this paper
• Biomarkers in heart failure.

  2008cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

  2007cited by this paper
• MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure

  2007cited by this paper
• Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.

  2007influential reference
• The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists

  2007cited by this paper
• MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy

  2007cited by this paper
• A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

  2006cited by this paper
• miRBase: microRNA sequences, targets and gene nomenclature

  2005cited by this paper
• Combinatorial microRNA target predictions

  2005cited by this paper
• The Database of Interacting Proteins: 2004 update

  2004cited by this paper
• N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes

  2002cited by this paper
• Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

  2002cited by this paper
• The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

  2001cited by this paper
• Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

  2000influential reference
• Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit.

  1999cited by this paper
• Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

  1982cited by this paper

• The Investigation of Plasma Micro RNAs as Noninvasive Biomarkers for the Prediction of In-Stent Restenosis

  2025cites this paper
• The European BestAgeing Study on microRNA candidates reveals distinct signatures with diagnostic and prognostic potential in cardiovascular disease

  2025cites this paper
• MiR-150-5p attenuates heart failure by targeting MMP14 to regulate vascular smooth muscle cell function

  2025cites this paper
• Periostin is a Pivotal Target of microRNA-150-5p in Cardiac Fibroblast Activation and Chronic Myocardial Infarction

  2025cites this paper
• In-Hospital Levels of Circulating MicroRNAs as Potential Predictors of Left Ventricular Remodeling Post-Myocardial Infarction

  2024cites this paper
• Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

  2024cites this paper
• MicroRNA-150 Deletion from Adult Myofibroblasts Augments Maladaptive Cardiac Remodeling Following Chronic Myocardial Infarction

  2024cites this paper
• Current Concepts in the Epigenetic Regulation of Cardiac Fibrosis.

  2024cites this paper
• Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease

  2024cites this paper
• Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction

  2023cites this paper
• SPRR1A is a key downstream effector of MiR-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation

  2023cites this paper
• The microRNA Expression Profiling in Heart Failure: A Systematic Review and Meta-Analysis

  2022cites this paper
• Contemporary non-invasive methods for the diagnosis of early cardiac dysfunction in young patients with beta-thalassemia major

  2022cites this paper
• MiR-150 blunts cardiac dysfunction in mice with cardiomyocyte loss of β1-adrenergic receptor/β-arrestin signaling and controls a unique transcriptome

  2022cites this paper
• MicroRNAs as Potential Biomarkers in Coronary Artery Disease

  2022cites this paper
• Involvement of circRNAs in the Development of Heart Failure

  2022cites this paper
• The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

  2022cites this paper
• From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction

  2022cites this paper
• Non-coding RNAs: Important participants in cardiac fibrosis

  2022cites this paper
• MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic Hoxa4

  2022cites this paper
• Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction

  2021cites this paper
• THE ROLE OF CFDNA CONCENTRATION IN VARIOUS CARDIAC DISEASES AND IT’S CORRELATION WITH COVENTIONAL BIOMARKERS

  2021cites this paper
• MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling

  2021cites this paper
• MicroRNA-183-3p Is a Predictor of Worsening Heart Failure in Adult Patients With Transposition of the Great Arteries and a Systemic Right Ventricle

  2021cites this paper
• Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline–rich protein 1A

  2021cites this paper
• CIRCULAR RNA – miRNA MEDIATED INTERACTION IN MYOCARDIAL INFARCTION

  2021cites this paper
• Serum microRNA-185 Levels and Myocardial Injury in Patients with Acute ST-segment Elevation Myocardial Infarction

  2021influential citation
• MicroRNAs in Acute ST Elevation Myocardial Infarction—A New Tool for Diagnosis and Prognosis: Therapeutic Implications

  2021cites this paper
• Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy

  2021cites this paper
• miRNAs in the development of left ventricular remodeling and post-myocardial infarction heart failure.

  2020cites this paper
• Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF κ B Pathway

  2020cites this paper
• Post-Myocardial Infarction Ventricular Remodeling Biomarkers—The Key Link between Pathophysiology and Clinic

  2020cites this paper
• Long-term prognostic potential of microRNA-150-5p in optimally treated heart failure patients with reduced ejection fraction. A pilot study.

  2020cites this paper
• Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction

  2020cites this paper
• Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: a pilot study

  2020cites this paper
• Extracellular vesicles derived from microRNA-150-5p-overexpressing mesenchymal stem cells protect rat hearts against ischemia/reperfusion

  2020cites this paper
• Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy

  2020cites this paper
• Identification of a miRNA Based-Signature Associated with Acute Coronary Syndrome: Evidence from the FLORINF Study

  2020cites this paper
• Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

  2020cites this paper
• MicroRNAs in Cardiovascular Disease.

  2020cites this paper
• Interactions Among Regulatory Non-coding RNAs Involved in Cardiovascular Diseases.

  2020cites this paper
• An Overview of Non-coding RNAs and Cardiovascular System.

  2020cites this paper
• Circulating miR-320a as a Predictive Biomarker for Left Ventricular Remodelling in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

  2020cites this paper
• Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection †

  2020cites this paper
• Circular RNA-Centered Regulatory Networks in the Physiopathology of Cardiovascular Diseases

  2020influential citation
• The association of P2Y12 inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery disease

  2020cites this paper
• Epigenetic Biomarkers in Cardiovascular Diseases

  2019cites this paper
• Myocardial Preservation

  2019cites this paper
• Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction.

  2019cites this paper
• The role of microRNAs in the development, regulation, and treatment of atrial fibrillation

  2019cites this paper
• The relevance of microRNA in post-infarction left ventricular remodelling and heart failure

  2019cites this paper
• Serum Circulating miR-150 is a Predictor of Post-Acute Myocardial Infarction Heart Failure.

  2019cites this paper
• Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

  2019cites this paper
• Measurement of circulating natriuretic peptides to identify community‐based patients at risk of incident heart failure — should we?

  2019cites this paper
• Cardiac Remodeling: The Course Toward Heart Failure – I. General Concepts

  2019cites this paper
• Circulating miRNAs as risk biomarkers of cardiovascular complications in patients with coronary artery disease: achievements and difficulties of recent years

  2019cites this paper
• Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction

  2019influential citation
• MiR-150-5p retards the progression of myocardial fibrosis by targeting EGR1

  2019cites this paper
• Circulating microRNAs to predict heart failure after acute myocardial infarction in women.

  2019cites this paper
• Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy

  2019cites this paper
• Dysregulated expression of STAT1, miR‐150, and miR‐223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosis

  2019cites this paper
• Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective.

  2019cites this paper
• MiR-574-5p: A Circulating Marker of Thoracic Aortic Aneurysm

  2019cites this paper
• Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts

  2019cites this paper
• MicroRNA-150 deficiency accelerates intimal hyperplasia by acting as a novel regulator of macrophage polarization.

  2019cites this paper
• Various aspects of inflammation in heart failure

  2019cites this paper
• MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients—A Systematic Review

  2019cites this paper
• Cardiomyocyte-Specific Cell-Free DNA as a Heart Failure Biomarker?

  2019cites this paper
• Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure

  2019cites this paper
• Overexpressing microRNA-150 attenuates hypoxia-induced human cardiomyocyte cell apoptosis by targeting glucose-regulated protein-94

  2018cites this paper
• Abnormal expression of miR-133a in patients with acute myocardial infarction following radical surgery for gastric cancer and the underlying mechanism

  2018cites this paper
• Non-coding RNAs as biomarkers for acute myocardial infarction

  2018cites this paper
• Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

  2018cites this paper
• Looking to the Future: Spotlight on Emerging Biomarkers for Predicting Cardiovascular Risk

  2018cites this paper
• MicroRNA‐150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF‐κB signaling pathway in mice with acute coronary syndrome

  2018cites this paper
• Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction

  2018cites this paper
• Non-coding RNAs and exercise: pathophysiological role and clinical application in the cardiovascular system.

  2018cites this paper
• Circular RNAs: a novel tool in cardiovascular biomarker development?

  2018cites this paper
• Noncoding RNAs in disease

  2018cites this paper
• Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction

  2018cites this paper
• Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study

  2018cites this paper
• Biomarqueurs transcriptomiques sanguins des maladies cardiovasculaires

  2018cites this paper
• Circular RNAs in the cardiovascular system

  2018cites this paper
• Circular RNA in cardiovascular disease

  2018cites this paper
• Reprint of: MicroRNA profiling of human intermediate monocytes.

  2017cites this paper
• Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study.

  2017cites this paper
• miRNA Update: A Review Focus on Clinical Implications of miRNA in Vascular Remodeling

  2017cites this paper
• Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.

  2017cites this paper
• Left Ventricular Remodeling after Acute Myocardial Infarction and Biomarkers

  2017cites this paper
• MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke

  2017cites this paper
• Circulating miRNA‑21 is a promising biomarker for heart failure.

  2017cites this paper
• miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204

  2017cites this paper
• Knockdown of Long Non‐Coding RNA‐ZFAS1 Protects Cardiomyocytes Against Acute Myocardial Infarction Via Anti‐Apoptosis by Regulating miR‐150/CRP

  2017cites this paper
• Preliminary Experiment Results of Left Ventricular Remodelling Prediction Using Machine Learning Algorithms

  2017cites this paper
• Platelet microRNA for predicting acute myocardial infarction

  2017influential citation
• miR-539 as a key negative regulator of the MEK pathway in myocardial infarction

  2017cites this paper
• The circular RNA MICRA for risk stratification after myocardial infarction☆

  2017cites this paper
• AT1 receptor blocker azilsartan medoxomil normalizes plasma miR-146a and miR-342-3p in a murine heart failure model

  2017cites this paper
• MicroRNAs as potential prognosticators of neurological outcome in out-of-hospital cardiac arrest patients.

  2017cites this paper
• MicroRNA profiling of human intermediate monocytes.

  2017cites this paper